XML 48 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Exit and disposal activities (Tables)
12 Months Ended
Aug. 31, 2017
Restructuring and Related Activities [Abstract]  
Restructuring costs and reserves
Restructuring costs by segment are as follows (in millions):

 
Retail Pharmacy
 
 
 
 
Fiscal 2017
USA
 
International
 
Pharmaceutical Wholesale
 
Consolidated
Asset impairments
$
272

 
$
21

 
$
2

 
$
295

Real estate costs
372

 

 

 
372

Severance and other business transition and exit costs
87

 
46

 
35

 
168

Total restructuring costs
$
731

 
$
67

 
$
37

 
$
835

 
 
 
 
 
 
 
 
Fiscal 2016
 

 
 

 
 

 
 

Asset impairments
$
215

 
$
10

 
$

 
$
225

Real estate costs
89

 
1

 
1

 
91

Severance and other business transition and exit costs
70

 
18

 
20

 
108

Total restructuring costs
$
374

 
$
29

 
$
21

 
$
424

 
 
 
 
 
 
 
 
Fiscal 2015
 

 
 

 
 

 
 

Asset impairments
$
216

 
$
7

 
$

 
$
223

Real estate costs
219

 

 

 
219

Severance and other business transition and exit costs
105

 
12

 

 
117

Total restructuring costs
$
540

 
$
19

 
$

 
$
559


The changes in accrued expenses and other liabilities related to the Cost Transformation Program include the following (in millions):

 
Asset
impairments
 
Real estate
costs
 
Severance and
other business
transition and
exit costs
 
Total
Balance at August 31, 2016
$

 
$
248

 
$
27

 
$
275

Restructuring costs
295

 
372

 
168

 
835

Payments

 
(99
)
 
(119
)
 
(218
)
Other - non cash
(295
)
 

 

 
(295
)
Currency translation adjustments

 

 
3

 
3

Balance at August 31, 2017
$

 
$
521

 
$
79

 
$
600